\(
\def\WIPO{World Intellectual Property Organisation}
\)
Reaping the benefits of genomic and proteomic research : intellectual property rights, innovation, and public health / Stephen A. Merrill and Anne-Marie Mazza, editors.
Merril, Stephen A., author.; Mazza, Anne-Marie.; Council, National Research.; Merrill, Stephen A., editor.; National Research Council (u.s.). Committee On Intellectual Property Rights In Genomic And Protein Research And Innovation.; National Research Council (Estados Unidos). Committee On Intellectual Property Rights In Genomic And Protein Research And Innovation.
2006
G 16 MER.R
Available at WIPO Library
Items
Details
Title
Reaping the benefits of genomic and proteomic research : intellectual property rights, innovation, and public health / Stephen A. Merrill and Anne-Marie Mazza, editors.
Author
Merril, Stephen A., author.
Mazza, Anne-Marie.
Council, National Research.
Merrill, Stephen A., editor.
Mazza, Anne-Marie.
Council, National Research.
Merrill, Stephen A., editor.
Description
xvi, 171 pages ; 23 cm
ISBN
0309100674
0309655234 electronic book
9780309655231 electronic book
9780309100670
1280447222
9781280447228
9786610447220
6610447225
0309655234 electronic book
9780309655231 electronic book
9780309100670
1280447222
9781280447228
9786610447220
6610447225
Alternate Call Number
G 16 MER.R
Summary
The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results.
Note
"Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation, Board on Science, Technology, and Economic Policy, Committee on Science, Technology, and Law, Policy and Global Affairs, National Research Council of the National Academies."
Formatted Contents Note
Genomics, proteomics, and the changing research environment
The U.S. patent system, biotechnology, and the courts
Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research
Conclusions and recommendations.
The U.S. patent system, biotechnology, and the courts
Trends in the patenting and licensing of genomic and protein inventions and their impact on biomedical research
Conclusions and recommendations.
Published
Washington, D.C. : National Academies Press, c2006.
Language
English
Record Appears in
all